Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BRNS

Barinthus Biotherapeutics Plc ADR

May 11 • 04:00PM ET

0.6850

+0.0150 2.24 %

Healthcare • Biotechnology • United Kingdom • Nano • NASD

Peers: BLRX XLO IMNN TNXP BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.29	Insider Own	3.48%	Shs Outstand	40.85M	Perf Week	7.87%
Market Cap	27.98M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	0.00%	Shs Float	39.43M	Perf Month	20.70%
Enterprise Value	-28.12M	PEG	-	EPS next Q	-0.28	Inst Own	15.86%	Short Float	0.02%	Perf Quarter	-3.18%
Income	-52.46M	P/S	-	EPS this Y	29.88%	Inst Trans	5.59%	Short Ratio	0.20	Perf Half Y	-42.44%
Sales	0.00M	P/B	0.42	EPS next Y	0.00%	ROA	-44.81%	Short Interest	0.01M	Perf YTD	-2.16%
Book/sh	1.62	P/C	0.42	EPS next 5Y	-	ROE	-57.68%	52W High	2.92 -76.54%	Perf Year	-20.99%
Cash/sh	1.64	P/FCF	-	EPS past 3/5Y	- -	ROIC	-69.57%	52W Low	0.51 33.79%	Perf 3Y	-69.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.50% 8.26%	Perf 5Y	-94.95%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	21.30%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.05	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	64.18	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.05	EPS Q/Q	72.40%	SMA20	8.95%	Beta	-0.41	Target Price	7.00
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	13.31%	Rel Volume	1.25	Prev Close	0.67
Employees	14	LT Debt/Eq	0.14	Earnings	Apr 30 BMO	SMA200	-23.65%	Avg Volume	37.94K	Price	0.69
IPO	Apr 30, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	50.00% -	Trades		Volume	49,536	Change	2.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)